Body fluid markers in people with narcolepsy
Part of Brain & nervous system, Mental health clinical trials.
This study looks at the proteins and other chemicals in body fluids (like blood or spinal fluid) of people with narcolepsy. The goal is to find markers that could help doctors better understand and diagnose narcolepsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a clear diagnosis of narcolepsy according to standard sleep disorder criteria.
- Your sleepiness should not be caused by shift work, lack of sleep, or drug use.
- You cannot have Parkinson's, Alzheimer's, or other serious nervous system or mental health disorders.
- You must not have serious heart, lung, liver, kidney, or blood disease, or a recent infection.
- You cannot have taken sedatives, sleeping pills, antidepressants, lithium, or dopamine-blocking drugs in the last two weeks.
- You must be able to undergo sleep studies (PSG and MSLT) without problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genes of people with narcolepsy who are of Black or North African background. The goal is to better understand the condition and improve diagnosis and treatment.
This study looks at how narcolepsy or idiopathic hypersomnia affects thinking and cardiovascular health, and how usual treatment medications may change those outcomes. It may help researchers understand risks and benefits of common hypersomnia therapies.
This study is looking at how common and how severe excessive daytime sleepiness (hypersomnia) is in children and teenagers with various sleep and developmental conditions. If your child has one of these conditions and struggles with sleepiness, they may be able to join to help doctors better understand and treat it.
This study compares “social cognition” (how people recognize and understand others’ thoughts and feelings) in adults with narcolepsy or idiopathic hypersomnia. It may help researchers better understand how these conditions can affect everyday social interactions.
This study tests a new drug called E2086 to see if it can help reduce daytime sleepiness and sudden muscle weakness in adults with narcolepsy. It involves two groups: people with cataplexy (type 1) and those without (type 2).
This study compares gut bacteria and substances from the gut in people with type 1 narcolepsy versus those without. It aims to understand how gut health might be linked to this sleep disorder.
Hear when a new Narcolepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.